We source, license and develop multiple portfolios of orthogonal, novel therapeutics programs to achieve major clinical and commercial inflection points
Vi bruger cookies til at analysere websitetrafik og optimere din websiteoplevelse. Når du accepterer vores brug af cookies, bliver dine data vist med alle andres brugerdata.